147 related articles for article (PubMed ID: 32825929)
21. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
22. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.
Kunju LP; Cookingham C; Toy KA; Chen W; Sabel MS; Kleer CG
Mod Pathol; 2011 Jun; 24(6):786-93. PubMed ID: 21399615
[TBL] [Abstract][Full Text] [Related]
23. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
Hou Y; Chaudhary S; Gao FF; Li Z
Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of apocrine lesions of the breast.
O'Malley FP; Bane AL
Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
[TBL] [Abstract][Full Text] [Related]
25. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
[TBL] [Abstract][Full Text] [Related]
26. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
27. Molecular and diagnostic features of apocrine breast lesions.
Gromov P; Espinoza JA; Gromova I
Expert Rev Mol Diagn; 2015; 15(8):1011-22. PubMed ID: 26111757
[TBL] [Abstract][Full Text] [Related]
28. Apocrine adenosis: a precursor of aggressive breast cancer?
Wells CA; McGregor IL; Makunura CN; Yeomans P; Davies JD
J Clin Pathol; 1995 Aug; 48(8):737-42. PubMed ID: 7560201
[TBL] [Abstract][Full Text] [Related]
29. The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast.
Genco IS; Hackman K; Morrar D; Jin C; Santagada E; Hajiyeva S
Pathol Int; 2021 Jun; 71(6):415-419. PubMed ID: 33730427
[TBL] [Abstract][Full Text] [Related]
30. Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast.
D'Arcy C; Quinn CM
J Clin Pathol; 2019 Jan; 72(1):7-11. PubMed ID: 30425121
[TBL] [Abstract][Full Text] [Related]
31. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
Seidman JD; Ashton M; Lefkowitz M
Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
[TBL] [Abstract][Full Text] [Related]
32. Apocrine lesions of the breast.
Quinn CM; D'Arcy C; Wells C
Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.
Shaaban AM; Sloane JP; West CR; Foster CS
Am J Pathol; 2002 Feb; 160(2):597-604. PubMed ID: 11839580
[TBL] [Abstract][Full Text] [Related]
34. [Papillary lesions of the breast].
Länger F; Hille-Betz U; Kreipe HH
Pathologe; 2014 Feb; 35(1):36-44. PubMed ID: 24430780
[TBL] [Abstract][Full Text] [Related]
35. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
Chang Sen LQ; Berg WA; Carter GJ
Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
[TBL] [Abstract][Full Text] [Related]
36. EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
Beca F; Kensler K; Glass B; Schnitt SJ; Tamimi RM; Beck AH
Breast Cancer Res; 2017 Mar; 19(1):21. PubMed ID: 28253895
[TBL] [Abstract][Full Text] [Related]
37. Atypical apocrine metaplasia: a diagnostic pitfall in fine needle aspiration cytology of the breast.
Ng WK; Kong JH; Wong WW
Acta Cytol; 2003; 47(4):698-701. PubMed ID: 12920771
[No Abstract] [Full Text] [Related]
38. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients.
Carter DJ; Rosen PP
Mod Pathol; 1991 Jan; 4(1):1-5. PubMed ID: 2020652
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic pitfalls in fine needle aspiration cytology of atypical apocrine metaplasia in a breast lesion. A case report.
Gupta D; Wolf JA; Rubenchik IA; Middleton LP
Acta Cytol; 2002; 46(4):749-52. PubMed ID: 12146046
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.
Jones C; Damiani S; Wells D; Chaggar R; Lakhani SR; Eusebi V
Am J Pathol; 2001 Jan; 158(1):207-14. PubMed ID: 11141494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]